Leaderdrive / 绿的谐波 S4-to-S5 Evidence Debt Artifact v1
Date: 2026-06-15
Owner: Hugo / Genius Team
Agent: Finance / Charlie AGT-002
Status: public-safe research artifact
Visibility: PUBLIC
Primary use: morning review, slide 10 speaker notes, /robotics/supply-chain case-study module
Related files:
knowledge/robotics-research-harness.mdknowledge/robotics-sharing-backlog.mdknowledge/robotics-supply-chain.mdknowledge/robotics-sources.mdknowledge/robotics-leaderdrive-public-case-v1.mdknowledge/robotics-leaderdrive-morning-review-public-packaging-guardrail-v1.mdknowledge/robotics-public-claim-bank-v1.md
Public-safety note:
- Public-safe: yes, if used as evidence map / case study only.
- No Hugo private portfolio data.
- No buy / sell / hold language for 688017.SH.
- No named-customer inference unless disclosed by primary source.
0. One-line answer
截至 2026-06-15,绿的谐波 / Leaderdrive 最有用的公开表达不是“humanoid winner”,而是“供应链 S4 证据债务案例”:2025 年报披露收入 RMB 570.714m(+47.31% YoY)、归母净利润 RMB 124.367m(+121.42% YoY)、谐波减速器销量 425,158 台(+72.48% YoY)、“工业及具身智能机器人零部件”收入 RMB 422.528m(+52.61% YoY,毛利率 34.88%);2026 Q1 披露收入 RMB 140.134m(+42.96% YoY)、归母净利润 RMB 32.634m(+61.17% YoY)。这些是强 S4 filing-backed supply-chain signals,但 reviewed public sources 仍未披露具名 humanoid OEM、合同金额、订单 volume、humanoid-only revenue/margin、single-robot value content 或 customer ROI/payback。🟢 2025 annual report and 2026 Q1 report disclosed 2026-04-23; 🟠 Charlie evidence-debt classification as of 2026-06-15.
1. What this artifact adds
已有文件已经能支持一个 sanitized public case。这个 v1 的增量是把 case study 改写成“证据债务”工具,方便早晨 review 时决定:哪些证据已经能进 slide/site,哪些必须留在 S5 missing bucket。
新增结构:
- 把 revenue / volume / product breadth / price-action caveat 拆成独立 evidence units。
- 给每个 evidence unit 标注 debt severity。
- 明确 S4→S5 upgrade trigger,而不是把报表增长直接等同为 humanoid thesis completion。
- 给 Codex 一个短模块:三张卡 + do-not-say list + footer。
2. Source verification snapshot
2026-06-15 quick reachability check:
| Source | URL / source | Retrieval result on 2026-06-15 | Source grade | Verification limitation |
|---|---|---|---|---|
| 绿的谐波 2025 annual report | SSE static PDF URL captured in existing source list | HTTP 200; server returned HTML wrapper / first 3,872 bytes sampled | 🟢 primary filing source, previously extracted | This run verifies URL reachability, not full PDF text extraction. Numeric anchors rely on previously extracted annual-report notes. |
| 绿的谐波 2026 Q1 report | SSE static PDF URL captured in existing source list | HTTP 200; server returned HTML wrapper / first 3,872 bytes sampled | 🟢 primary filing source, previously extracted | Same limitation. |
| 绿的谐波 2026-06-09 abnormal-trading announcement | SSE static PDF URL captured in existing source list | HTTP 200; server returned HTML wrapper / first 3,872 bytes sampled | 🟢 primary filing source, previously extracted | Same limitation. |
| Leaderdrive official site | https://www.leaderdrive.com/ | HTTP 200; first 4,096 bytes sampled | 🟢 company official | Reachability only; not a customer/order proof. |
| Leaderdrive product page | https://www.leaderdrive.com/product/ | HTTP 200; first 4,096 bytes sampled | 🟢 company official | Product availability / fit does not equal production order. |
Method: Python urllib.request with browser-like user-agent in /home/ubuntu/personal-ai/workspace/finance, run 2026-06-15. 🟠 method note.
3. Evidence units vs evidence debt
| Evidence unit | What is proven | Current signal | Evidence debt | Debt severity | Interpretation |
|---|---|---|---|---|---|
| 2025 revenue / profit acceleration | Revenue RMB 570.714m, +47.31% YoY; attributable net profit RMB 124.367m, +121.42% YoY. 🟢 2025 annual report, disclosed 2026-04-23 | S4 filing-backed operating acceleration | How much of growth is humanoid-specific vs industrial robot / general embodied-intelligence / cycle recovery. | High | Stronger than concept-stock language, but not yet humanoid-only validation. |
| Robot / embodied-intelligence reporting line | “工业及具身智能机器人零部件” revenue RMB 422.528m, +52.61% YoY, gross margin 34.88%. 🟢 2025 annual report | S4 reporting-line signal | Humanoid-only split, named customer, order duration, backlog and margin by end-market. | High | The line is valuable because it is filing-backed; it must not be compressed into pure humanoid revenue. |
| Harmonic reducer volume | Harmonic reducer production 433,655 units (+72.27% YoY), sales 425,158 units (+72.48% YoY), inventory 18,238 units (-6.34% YoY). 🟢 2025 annual report | S4 volume signal | Which portion maps to humanoid / embodied-intelligence customers, ASP by use case, customer concentration and repeat demand. | Medium-high | Volume growth supports supply-chain acceleration; it does not identify the downstream robot platforms. |
| 2026 Q1 follow-through | Q1 revenue RMB 140.134m (+42.96% YoY), attributable net profit RMB 32.634m (+61.17% YoY). 🟢 2026 Q1 report, disclosed 2026-04-23 | S4 continuation signal | Whether growth continues through 2026 with margin stability and clean cash conversion. | Medium | Useful continuation evidence, but still early and not customer-specific. |
| Product breadth / architecture hedge | Public materials reference harmonic reducers, micro reducers, rotary actuators, frameless torque motors, planetary roller screws / linear transmission, planetary joint modules and DD motors. 🟢 annual report / official pages / prior evidence files | S3/S4 architecture-fit signal | Revenue by newer actuator / PRS / linear products; validated humanoid BOM attach; qualification status. | Medium | Product breadth reduces single-architecture risk, but product display is not order proof. |
| Abnormal-trading caveat | 2026-06-04 to 2026-06-08 share price +36.00% vs SSE Composite -3.05% and automation-equipment index +2.13%; company said no undisclosed major matter. 🟢 abnormal-trading announcement, 2026-06-09 | S3 anti-hype / risk-control signal | None for order proof; this is mainly a boundary source. | Medium | Prevents public packaging from implying price action equals new customer/order evidence. |
4. Current classification
Current stage: S4 supply-chain validation; not S5 scaled humanoid commercialization proof. 🟠 as of 2026-06-15.
Why S4:
- Financial statement evidence exists: revenue, profit, robot-parts reporting line, unit shipments and Q1 follow-through. 🟢
- Product architecture relevance exists across reducer / actuator / PRS / linear / joint-module surfaces. 🟢/🟠
- Abnormal-trading announcement gives a useful anti-hype boundary. 🟢
Why not S5:
- No reviewed primary source discloses named humanoid OEM customer. 🟢/🟠
- No reviewed primary source discloses contract value, order volume, backlog duration or humanoid-specific revenue/margin. 🟢/🟠
- No customer-side source discloses downstream robot deployment ROI/payback tied to Leaderdrive modules. 🟢/🟠
- No public source validates single-robot value content or actual BOM attach in a production humanoid platform. 🟢/🟠
5. Evidence-debt priority order
P0 — would change the case fastest
-
Named humanoid OEM design win with supply scope, volume, contract period or order amount. 🟢 needed.
- Why P0: It converts product fit + reporting-line evidence into customer validation.
- Current status: absent from reviewed public filings / source packets as of 2026-06-15. 🟢/🟠
-
Humanoid-specific revenue / backlog / margin disclosed separately from broader industrial + embodied-intelligence components. 🟢 needed.
- Why P0: It prevents over-reading RMB 422.528m as pure humanoid revenue.
- Current status: absent from reviewed public filings as of 2026-06-15. 🟢/🟠
-
Segment margin durability while robot-related revenue grows above ~30% YoY. 🟢/🟠 threshold.
- Why P0: The 34.88% reported gross margin is a key baseline; humanoid ramp matters only if value capture survives ASP pressure, competition and OEM bargaining.
- Current status: one strong 2025 baseline plus 2026 Q1 continuation, but not enough multi-period humanoid-specific data. 🟢/🟠
-
Validated BOM / teardown / customer-side confirmation that Leaderdrive modules are in production humanoid platforms. 🟢/🟡 needed.
- Why P0: It ties product breadth to actual platform attach.
- Current status: absent in reviewed public-safe source set. 🟢/🟠
P1 — strengthens / weakens S4 quality
- Revenue growth accompanied by stable inventory, receivables and operating cash flow quality. 🟢 needed.
- New actuator / PRS / linear products becoming material revenue contributors. 🟢 needed.
- Repeat customer orders or longer supply agreements, even if customer names remain partly undisclosed. 🟢/🟠 needed.
- Competitor ASP / margin evidence showing whether harmonic reducers are commoditizing. 🟡/🟠 useful.
P2 — useful but not thesis-changing alone
- More product-exhibition photos without revenue/customer link. 🟢 for product existence / 🟠 for commercialization.
- Sell-side / social supply-chain lists without primary customer confirmation. 🟡/🔴.
- Stock-price movement without disclosed operating update. 🔴 as proof; 🟢 only as market-context.
6. Public slide / site module draft
Suggested title
绿的谐波:强报表信号,不等于已验证 humanoid winner
Three-card layout
-
What is proven 🟢
- 2025 revenue RMB 570.714m, +47.31%; net profit RMB 124.367m, +121.42%.
- “工业及具身智能机器人零部件” revenue RMB 422.528m, +52.61%, GM 34.88%.
- Harmonic reducer sales 425,158 units, +72.48%.
- 2026 Q1 revenue RMB 140.134m, +42.96%; net profit RMB 32.634m, +61.17%.
-
Why it matters 🟢/🟠
- This is filing-backed revenue / profit / unit-volume evidence, stronger than concept-stock narrative.
- Product breadth covers reducer, micro reducer, rotary actuator, frameless motor, PRS / linear actuator, planetary joint module and DD motor surfaces.
- Current public grade: S4 supply-chain validation.
-
What remains missing before S5 🟢/🟠
- Named humanoid OEM customer.
- Contract value / backlog / order volume.
- Humanoid-specific revenue and gross margin.
- Single-robot value content / validated BOM attach.
- Downstream customer ROI/payback and repeat deployment economics.
- Margin durability if volume scales.
Required footer: Evidence map only. No trade recommendation. No private portfolio data. Product fit ≠ customer proof; stock-price move ≠ order evidence.
7. Signal vs noise
Signal
- Filing-backed revenue, profit, reporting-line and unit-volume acceleration. 🟢 S4.
- Q1 follow-through after 2025 acceleration. 🟢 S4 continuation.
- Product expansion beyond discrete harmonic reducers. 🟢/🟠 S3/S4 architecture hedge.
- Abnormal-trading announcement saying no undisclosed major matter after +36.00% three-trading-day move. 🟢 S3 caution.
Noise unless upgraded
- “Leaderdrive supplies Tesla / Figure / Unitree” without primary customer disclosure, filing evidence, teardown or identifiable production-part evidence. 🔴
- “RMB 422.528m is humanoid revenue.” Incorrect compression: the filing line is industrial + embodied-intelligence robot components, not humanoid-only. 🟢/🟠
- “Share price +36% proves new order.” Contradicted as order evidence by the abnormal-trading disclosure boundary. 🟢/🔴
- “Every humanoid requires fixed N harmonic reducers.” Only usable as an estimate with explicit method. 🟠/🔴
- “Product display means large order.” Product fit is not revenue, customer, margin or repeat order proof. 🟢/🟠
8. Common misconceptions
-
Misconception: “绿的谐波已经证明 humanoid 商业化。”
- Correction: 它证明的是 component supplier 的 S4 filing-backed acceleration;下游 humanoid customer economics 仍未披露。🟢/🟠
-
Misconception: “RMB 422.528m 就是 humanoid revenue。”
- Correction: 披露口径是“工业及具身智能机器人零部件”,不是 humanoid-only revenue。🟢
-
Misconception: “供应链收入比 OEM 部署证据更确定。”
- Correction: 供应链收入可以更早进报表,但仍面对 OEM 议价、ASP 下降、客户集中、垂直整合、架构替代和 inventory/receivables 质量风险。🟠
-
Misconception: “股价上涨证明订单。”
- Correction: 2026-06-09 abnormal-trading announcement 说不存在应披露而未披露的重大事项;股价是市场信号,不是订单证据。🟢
-
Misconception: “谐波减速器是唯一价值池。”
- Correction: humanoid value may migrate among reducers, integrated actuators, PRS / linear actuators, motors, sensors, batteries, compute, model/software and deployment service. 🟠
9. Think Deeper questions
- 如果 humanoid 放量但低价 OEM 强压 ASP,上游供应商是受益于 volume,还是损失在 margin?
- “工业及具身智能机器人零部件”这类混合口径,最低要拆到什么程度才足以支撑 S5 thesis:customer、use-case、humanoid-only revenue、还是 margin?
- 如果 integrated actuator 取代部分 discrete harmonic reducer,Leaderdrive 的产品扩张会增加 per-robot value content,还是只是防守?
- 供应链公司先进入 revenue validation,OEM 先进入 deployment KPI validation;两类证据应该如何互相校验?
- 若股价已经先行反映主题,而 filings 仍无具名客户,该如何在 public field guide 里表达“强信号 + 强边界”?
10. Do-not-say list for Codex
- Do not say 688017.SH is buy / sell / hold. 🔴
- Do not include Hugo private portfolio weight, entry logic, or private rationale. 🔴
- Do not infer Tesla / Figure / Unitree / AgiBot / UBTECH as customers without source-backed confirmation. 🔴
- Do not call “工业及具身智能机器人零部件” pure humanoid revenue. 🔴
- Do not treat share-price movement as customer/order evidence. 🔴
- Do not use estimated reducer counts or BOM values as facts unless labeled 🟠 estimate with method. 🔴
- Do not turn the case study into a valuation pitch.
11. Source list
Primary sources 🟢:
- 绿的谐波 2025 annual report, disclosed 2026-04-23: https://static.sse.com.cn/disclosure/listedinfo/announcement/c/new/2026-04-23/688017_20260423_EU45.pdf
- Used for: 2025 revenue RMB 570.714m; net profit RMB 124.367m; “工业及具身智能机器人零部件” revenue RMB 422.528m and GM 34.88%; harmonic reducer production / sales / inventory; product lines.
- 绿的谐波 2026 Q1 report, disclosed 2026-04-23: https://static.sse.com.cn/disclosure/listedinfo/announcement/c/new/2026-04-23/688017_20260423_TB4A.pdf
- Used for: Q1 revenue RMB 140.134m; net profit RMB 32.634m; Q1 follow-through.
- 绿的谐波 2026-06-09 abnormal-trading announcement: https://static.sse.com.cn/disclosure/listedinfo/announcement/c/new/2026-06-09/688017_20260609_MZU2.pdf
- Used for: 2026-06-04 to 2026-06-08 price move +36.00% vs SSE Composite -3.05% and automation-equipment index +2.13%; no undisclosed major matter caveat.
- Leaderdrive official site: https://www.leaderdrive.com/ 🟢
- Leaderdrive products page: https://www.leaderdrive.com/product/ 🟢
Internal synthesis / cross-reference 🟠:
knowledge/robotics-leaderdrive-public-case-v1.mdknowledge/robotics-leaderdrive-morning-review-public-packaging-guardrail-v1.mdknowledge/robotics-public-claim-bank-v1.mdknowledge/robotics-supply-chain.md
12. Public-safe flag
Public-safe: yes, if used as an evidence-debt map and not as a recommendation.
Exclude:
- Hugo private portfolio data.
- Buy / sell / hold language.
- Named-customer claims not present in primary sources.
- Paid-report excerpts or private channel checks.
- Any implication that S4 filing-backed supplier validation equals S5 scaled humanoid commercialization proof.